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Abstract
Background: Leucine zipper/EF hand-containing transmembrane-1 (LETM1) encodes for the human homologue of yeast
Mdm38p, which is a mitochondria-shaping protein of unclear function. However, a previous study demonstrated that
LETM1 served as an anchor protein for complex formation between mitochondria and ribosome, and regulated
mitochondrial biogenesis.
Methodology/Principal Findings: Therefore, we examine the possibility that LETM1 may function to regulate mitochondria
and lung tumor growth. In this study, we addressed this question by studying in the effect of adenovirus-mediated LETM1
in the lung cancer cell and lung cancer model mice. To investigate the effects of adenovirus-LETM1 in vitro, we infected with
adenovirus-LETM1 in A549 cells. Additionally, in vivo effects of LETM1 were evaluated on K-ras
LA1 mice, human non-small
cell lung cancer model mice, by delivering the LETM1 via aerosol through nose-only inhalation system. The effects of LETM1
on lung cancer growth and AMPK related signals were evaluated. Adenovirus-mediated overexpression of LETM1 could
induce destruction of mitochondria of lung cancer cells through depleting ATP and AMPK activation. Furthermore,
adenoviral-LETM1 also altered Akt signaling and inhibited the cell cycle while facilitating apoptosis. Theses results
demonstrated that adenovirus-LETM1 suppressed lung cancer cell growth in vitro and in vivo.
Conclusions/Significance: Adenovirus-mediated LETM1 may provide a useful target for designing lung tumor prevention
and treatment.
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Introduction
Lung cancer is the leading cause of cancer deaths in the world
with over one million cases diagnosed every year. Multiple options
for the treatment of lung cancer have been described, including
surgery, chemotherapy, and radiation, however, therapeutic effect
is typically transient and mostly absent with advanced disease
[1,2]. Therefore, the need of more rational approach to lung
cancer therapy is essential.
Recently, mitochondria have emerged as effective target for
anti-cancer therapy [3]. Mitochondria are multifunctional organ-
elles of changing morphology whose activities are intimately tied to
cell physiology [4]. Fragmented mitochondrial morphology, for
example, is correlated with apoptotic cytochrome c release,
whereas tubular morphology promotes resistance to apoptotic
stimuli. Also, mitochondria function as central components of cell
survival through ATP production and govern cell fate by
mitochondrial membrane-dependent cell death signal [5].
Cellular energy is largely derived from the process of oxidative
phosphorylation in the mitochondria. The status of cellular energy
stores is monitored by AMP-activated protein kinase (AMPK).
AMPK is activated to reserve cellular energy content, and serves
PLoS ONE | www.plosone.org 1 September 2010 | Volume 5 | Issue 9 | e12535as a key regulator of cell survival or death in response to
pathological stresses [6,7]. Under conditions of ATP depletion,
AMPK is allosterically activated by the binding of AMP to
AMPK, which facilitates phosphorylation of AMPK on Threonine
172 [8,9]. Since AMPK is associated with many critical cellular
events, considerable amount of efforts has devoted to elucidate
whether AMPK is implicated in cancer cell growth and
metabolism. In fact, recent line of evidence suggest that the
inactivation of AMPK augments malignant behaviors of prostate
cancer cells and its activation suppresses their growth [10].
Cell cycle progression is intricately controlled under many
checkpoints which respond to intrinsic and extrinsic signals.
During the G1 phase, cells integrate the mitogenic as well as
growth inhibitory signals, then, make decision to proceed, pause,
or exit the cell cycle [11,12]. There is growing evidence that the
G1-S transition during cell cycle is also regulated by metabolic
events, suggesting the possible existence of a metabolic or
energetic checkpoint. Some studies have indicated that a round
of cell cycle and mitochondrial oxidative capacity are greater at
late G1 than early G1. Also, the reduction of mitochondrial ATP
production blocks G1-S transition of the cell cycle, thus, affects
mitochondrial function or shape [13,14]. These studies have
suggested that the metabolic checkpoint integrates not only
external growth stimuli and nutrient availability but also the
potential synchronization of intrinsic mitochondrial metabolism
with cell cycle progression.
Leucine zipper/EF hand-containing transmembrane-1 (LETM1)
is a mitochondrial inner membrane protein that was first identified
inWolf-Hirschhorn syndrome,and wasdeleted innearlyallpatients
with the syndrome [15]. LETM1 encodes for the human
homologue of yeast Mdm38p, which is a mitochondria-shaping
protein of unclear function. However, a previous study demon-
strated that LETM1 served as an anchor protein for complex
formation between mitochondria and ribosome, and regulated
mitochondrial biogenesis [16]. Also, a recent study determined that
LETM1 was associated with carboxyl-terminal modulator protein
(CTMP), a negative regulator of Akt [17].
Together, the potential importance of LETM1 as a potential
tumor suppressor gene with poor prognosis of diverse oncogenic
nononcogenic lung diseases have prompted us to examine the
possibility that LETM1 may function to regulate mitochondria
and lung tumor growth. Here, we report that adenovirus-mediated
LETM1 overexpression can induce the AMPK activity and inhibit
the cell cycle progression through selective destruction of
mitochondria with ATP depletion. Our results support the
hypothesis that LETM1 may function as a tumor suppressor gene
for lung cancer therapy as well as prevention.
Results
LEMT1 reduced mitochondrial ATP production and
increased AMPK protein level
LETM1 plays a role in the regulation of mitochondrial
network and biogenesis, thus, the expression levels of mitochon-
drial proteins were analyzed. Adenovirus-mediated LETM1
transfection increased the LETM1 protein while heat shock
protein 60 (HSP60), the mitochondrial outer membrane (OM)
protein voltage-dependent anion channel (VDAC), and the
mitochondrial inner membrane (IM), and protein apoptosis-
inducing factor (AIF) remained unchanged (Left columns of
Fig. 1A and 1B). Among mitochondrial-encoding respiration
chain proteins such NADH:ubiquinone oxidoreductase 6 (ND6),
a complex I subunit; succinate dehydrogenase complex subunit A
(SDHA), a complex II subunit; and cytochrome c, complex III
subunit; cytochrome c oxidase IV (COXIV), a complex IV
subunit, only the protein level of COXIV was selectively
decreased (Right columns of Fig. 1A and 1B). To further
evaluate the precise effects of a selective increase of LETM1 and
decrease of COXIV, we monitored the change of ATP level.
Analysis of relative mitochondrial ATP amounts using COX-8
luciferase revealed that the mitochondrial ATP level was
significantly reduced in LETM1 overexpressed cells compared
to control (Fig. 1C), indicating that LETM1 inhibited the
production of mitochondrial ATP. Since AMPK is activated to
reserve cellular energy content as described earlier, we investi-
gated the changes in protein expression of total AMPK, phospho-
AMPK at Thr 172 by LETM1 overexpression. Our result
showed that LETM1 significantly increased phospho-AMPK at
Thr 172 compared to total AMPK protein in vitro (Fig. 1D and
1E). Such AMPK activation has been reduced by the treatment
of siRNA LETM1 as a function of time (Fig. 1F). Immnuo-
fluorescence analysis also clearly confirmed that adenovirus-
LETM1 increased the expression of phospho- AMPK at Thr 172
in A549 cells (Fig. 1G).
LETM1 inhibited the Akt/mTOR pathway
The in vitro findings were also reproduced in K-ras
LA1 murine
lung cancer model treated adenovirus-LETM1 via aerosol (Fig. 2A
and 2B), suggesting that loss of ATP level in adenovirus-LETM1
infected cells causes AMPK activation. Energy depletion also
affects the activity PI3-kinase/Akt pathway [18]. To investigate
whether LETM1 overexpression would alter the Akt activity in
vivo, Western blot analysis was performed. Our result showed that
adenovirus-mediated LETM1 inhibited Akt1 activity significantly
through suppression of phosphorylation at Thr308 and Ser473 as
well (Fig. 2C). We also confirmed that knockdown of AMPK by
siRNA and infected adenovirus-LETM1 inhibited Akt1 activity
through suppression of phosphorylation at Thr308 (Fig. 2E). Also,
adenovirus-mediated LETM1 significantly decreased phospho-
mTOR at Ser 2448 expression level (Fig. 2C). Densitometry
analysis of bands-of-interest clearly confirmed the result of
Western blot analysis (Fig. 2D).
LETM1 caused G1/S phase cell cycle arrest
Since AMPK pathway functions as a cellular energy-sensing
checkpoint that controls cell proliferation [19], the effects of
LETM1 on cell proliferation were measured. Analysis of cell cycle
distribution using flow cytometry revealed that LETM1 signifi-
cantly increased the G1/G0 subpopulation in time-dependent
manner (Fig. 3A and 3B), suggesting that LETM1 inhibited cell
cycle progression from G0/G1 into S phase as a function of
LETM1 overexpression (Fig. 3C). To further confirm these results,
several representative cell cycle-related proteins were analyzed by
Western blot analysis. As shown in Fig. 3D and E, adenovirus-
mediated LETM1 suppressed the proteins important for cell cycle
regulation such as cyclin D1, cyclin-dependent kinase 4(CDK4) in
A549 cells. In contrast, cellular levels of p53 phosphorylation and
inhibitors of CDK such as p21 were increased significantly (Fig. 3D
and 3E). Such changes of cell cycle-related genes were also found
similarly in in vivo study. As shown in Figure 4A and B, aerosol
delivery of adenovirus-mediated LETM1 suppressed the protein
expression of CDK4 and cyclin D1, however, the level of p21, p27
and phospho-p53 at Ser15 were increased. Increased p53
phosphorylation at Ser15 was further confirmed by immunohis-
tochemistry (Fig. 4C) and statistical analysis of phospho-p53 at
Ser15 positive cell counts (Fig. 4D) in the lung of K-ras
LA1 mice
treated with aerosol-containing adenovirus-LETM1. We also
confirmed that all changes including AMPK activation as well as
LETM1 Suppresses Lung Cancer
PLoS ONE | www.plosone.org 2 September 2010 | Volume 5 | Issue 9 | e12535Figure 1. Effects of LETM1 on mitochondria biogenesis and AMPK activity. A549 cells were infected with GFP (Ad-GFP), LETM1 (Ad-LETM1),
or without adenovirus (Control) for 48 h. (A) Mitochondria proteins were analyzed by immunoblotting with the indicated antibodies [mitochondrial-
encoding respiration chain proteins: NADH: ubiquinone oxidoreductase 6 (ND6), a complex I subunit; succinate dehydrogenase complex subunit A
(SDHA), a complex II subunit; and cytochrome c, complex III subunit; COXIV, a complex IV subunit and another mitochondrial protein: apoptosis-
inducing factor (AIF), heat shock protein 60 (HSP60), and voltage-dependent anion channel (VDAC)]. (B) The bands-of-interest were further analyzed
by densitometry. (C) Mitochondrial ATP was measured by luciferase assay. (D) Expression level of phospho-AMPK at Thr172 and AMPK proteins. (E)
The bands-of-interest were further analyzed by densitometry.(F) A549 cells were transfected with siRNA LETM1 in time-dependent manner and then
Western blot analysis of phospho-AMPK at Thr172. (G) Cells were fixed and immunostained with anti-phospho-AMPK (Thr172) antibody and then
visualized on a confocal microscope. Each bars represent mean6SE (n=3), *P,0.05 was considered significant and **P,0.01 highly significant
compared with corresponding control values.
doi:10.1371/journal.pone.0012535.g001
LETM1 Suppresses Lung Cancer
PLoS ONE | www.plosone.org 3 September 2010 | Volume 5 | Issue 9 | e12535cell cycle arrest were closely associated with LETM1 because
LETM1 knockdown (shRNA LETM1) as well as the blocking of
LETM1 delivery into mitochondria reversed the LETM1-
mediated events (Fig. 4E).
LETM1 altered mitochondrial morphology
Mitochondria are morphologically dynamic organelles that
continuously divide and fuse to form small individual units or
interconnected networks within the cell. To detect the mitochon-
Figure 2. LETM1 inhibits Akt/mTOR pathway in vivo. The 9 weeks K-ras
LA1 mice were exposed to aerosols containing adenovirus-LETM1 twice a
week for total 4 weeks. Lung tissue homogenates were subjected to western blot analysis. (A) Expression level of LETM1, phospho-AMPK at Thr172
and AMPK proteins. (B) The bands-of-interest were further analyzed by densitometry. (C) Expression level of Akt, phospho-Akt at Ser473, phospho-Akt
at Thr308, mTOR and phospho-mTOR at Ser2448 proteins. (D) The bands-of-interest were further analyzed by densitometry. Each bar represents
mean6SE (n=8), *P,0.05 was considered significant and **P,0.01 highly significant compared with corresponding control values. (E) The effect of
only siRNA AMPK or with infected adenovirus-LETM1 and protein expression level of AMPK and phospho-Akt at Thr 308.
doi:10.1371/journal.pone.0012535.g002
LETM1 Suppresses Lung Cancer
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by confocal laser scanning microscopy (CLSM) and transition
electron microscopy (TEM) was performed. Overexpression of
LETM1 in A549 cells caused fragmented pattern of mitochondria
morphology demonstrated by CLSM (Fig. 5A). TEM analysis
clearly demonstrated the disruption of mitochondria cristae
organization in A549 cells (Fig. 5B). Such destruction of
mitochondrial cristae was clearly reproduced in the lung of K-
ras
LA1 mice treated with aerosol-containing LETM1 (Fig. 5C).
These results demonstrate clearly that LETM1 causes mitochon-
drial morphologic changes.
LETM1 induced in vitro and in vivo apoptosis
It is known that the anti-apoptotic Bcl-2 family members, such
as Bcl-2 and Bcl-XL, are able to bind BAX and sequester them in
protein complexes to prevent triggering of apoptosis [20].
However, activation of BAX has been proposed to result in
formation of homomultimeric pore, permeabilization of mito-
chondrial membrane to initiate cytochrome c release, suggesting a
mechanistic link between mitochondrial morphology and apopto-
sis. Our results demonstrated that overexpression of LETM1
resulted in release of cytochrome c from the mitochondria to
cytosol (Fig. 6A and 6B). Also, adenovirus-LETM1 reduced
mitochondrial membrane potential compared with GFP and
Control group (Fig. S1A). Futhermore, annexin V flow cytometric
analysis reconfirmed the above findings. As shown in Fig. S1C,
28.20% of Annexin V-positive cells were detected in A549 cells
infected with adenovirus-LETM1 compared to control and others.
To further confirm this finding in in vivo murine experiment, we
delivered adenovirus-LETM1 to K-ras
LA1 mice via aerosol and
examined the changes in protein expression of apoptosis-related
proteins. Our result showed that aerosol delivery of LETM1
significantly increased BAX and active-PARP protein level while
decreasing the Pro-PARP protein. In contrast, aerosol delivered-
LETM1 decreased Bcl-xL protein level in the lung of LETM1-
delivered mice (Fig. 6C, 6D and Fig. S2). Immunohistochemistry
analysis also clearly confirmed that aerosol delivered adenovirus-
LETM1 increased the expression of active-PARP in the lung of K-
ras
LA1 mice (Fig. 6E and 6F). These results clearly indicated that
adenovirus-LETM1 induced apoptosis both in vitro and in vivo.
LETM1 inhibited lung tumorigenesis
To investigate the effect of adenovirus-LETM1 on the growth of
lung cancer, we examined such potential anti-tumor effects in K-
ras
LA1 mice. For the purpose, we analyzed the effect of LETM1 on
tumor cell proliferation using proliferating cell nuclear antigen
(PCNA) antibody. LETM1 significantly reduced the expression
and number of cells exhibiting PCNA expression (Fig. 7A and 7B).
Immunohistochemistry and PCNA positive cell labeling index
analysis demonstrated that aerosol delivered adenovirus-LETM1
decreased the expression of PCNA in the lung of K-ras
LA1 mice
significantly (Fig. 7C and 7D). Our results clearly indicated that
adenovirus-LETM1 suppressed cancer cell proliferation in the
lungs of human lung cancer model mice (Fig. S2A and S2B). Also,
similar results were also observed in cell proliferation assays (Fig.
S1B). Furthermore, histopathological analysis was performed in
the lungs of K-ras
LA1 mice. Aerosol delivery of LETM1 twice a
week for a month suppressed lung tumor mass (Fig. 7E, green
arrows). Such suppression of lung tumor formation was further
confirmed by histopathological examination (Fig. 7F, red circles).
The nodules developed in the lungs of control group (CON) and
GFP-treated group (GFP) were in general alveolar/bronchial
adenoma. In contrast, the lung hyperplasia was frequently
observed in LETM1-treated group (LETM1) in which progression
to adenoma was inhibited as shown in Fig. 7F and Table 1.
Furthermore, the total tumor number was significantly decreased
by adenoviral LETM1 delivery in the lungs. Also, tumor
angiogenesis is an important prognostic marker for many solid
tumors, including lung cancer that independently predicts
pathologic stages of tumor progression and tumor growth rate
[21]. Therefore, we examined expression level of MMP-2, MMP-
9, CD31 and VEGF in the lungs of K-ras
LA1 mice. Aerosol
delivery of LETM1 decreased MMP-2 and MMP-9 protein level
compared to those of control and vector control (Fig. S3). These
results showed that LEM1 overexpression may play a key role in
suppressing the lung cancer growth and progression (summery in
table1, Fig 7 and Fig. S4).
Discussion
Mitochondria are key players in several cellular functions
including growth, division, energy metabolism, and apoptosis [22].
Mitochondrial dysfunctions have been associated with various
human diseases including cancers [23].
Recent findings have shown that LETM1 regulates mitochon-
drial biogenesis and translation system which can be implicated in
tumorigenesis and cancer [17]. Therefore, this study was designed
to investigate the tumor suppressor function of LETM1 and clarify
the mechanism underlying tumor growth inhibition in lung cancer
model.
It has been shown that functional mitochondria are required for
all cell processes due to common energetic requirements [24].
Cytochrome c oxidase or complex IV, catalyzes the final step in
mitochondrial electron transfer chain, and is regarded as one of
the major regulation sites for oxidative phosphorylation. A detail
biosynthetic and functional analysis of several cell lines with
suppressed COX IV expression revealed a loss of assembly of
cytochrome c oxidase complex and, correspondingly, a reduction
in cytochrome c oxidase-dependent respiration and total respira-
tion [25]. Furthermore, dysfunctional cytochrome c oxidase in the
cells leads to a decreased ATP level. In our study, we showed that
LETM1 overexpression decreased specific mitochondrial protein
cytochrome c oxidase subunit IV resulting in a reduction of
mitochondrial ATP level in lung cancer cells (Fig. 1). AMPK is
now emerging as a modulator of different cellular responses, all
converging in the restoration of ATP levels. Elevated AMP/ATP
ratio activates AMPK, which inhibits energy-consuming processes
and activates energy-producing processes to restore the energy
homeostasis in the cell [26]. In this study, increased LETM1
phosphorylates AMPK on Threonine172 leading to activation of
the energy sensor AMPK (Fig. 1D, 1E, 1F, Fig. 2A, 2B, 2E and
Fig. 4E). Our findings are supported by recent works that AMPK
activation led to inhibition of prostate cancer cell growth [10] and
anti-pulmonary tumor effects of deguelin by AMPK activation
with Akt inactivation [27].
Figure 3. LETM1 causes cell cycle arrest in G1-S phase in vitro. A549 cells was infected with GFP (Ad-GFP), LETM1 (Ad-LETM1), or without
adenovirus (Control) for the indicated times. (A) Cell cycle distribution was determined by FACS. (B) Percentage of G1/G0 phase cell population. (C)
Expression of LETM1 Protein for different times. (D) Expression of p21, cyclinE, cyclinD1, CDK4, p27, phospho-p53 at Ser15 and p53 proteins. (E)The
bands-of-interest were further analyzed by densitometry. Each bars represent mean6SE (n=3), *P,0.05 was considered significant and **P,0.01
highly significant compared with corresponding control values.
doi:10.1371/journal.pone.0012535.g003
LETM1 Suppresses Lung Cancer
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was recently found to translocate into the mitochondria matrix in
response to insulin stimulation. mTOR, as a downstream protein
of Akt, is a key regulator of protein synthesis responding to growth
factor as well as metabolic control [28]. AMPK has been reported
to inhibit the activity of mTOR and the phosphorylation-mediated
activation of 70-kDa ribosomal protein S6 kinase (p70S6K), events
linked to the inhibition of cell proliferation and induction of a pro-
apoptotic environment [29]. Our results clearly showed that
aerosol delivery of LETM1 decreased Akt phosphorylation at
Thr308/Ser473 and mTOR phosphorylation at Ser2448, respec-
tively. However, an increase was observed in the levels of
phosphorylated AMPK (Fig. 2C and 2D). These results strongly
suggest that AMPK activation by overexpression of LETM1 can
alter cancer cell growth through the inhibition of Akt/mTOR
signaling pathway.
Recent studies have suggested that inhibitors of CDK activity
are important mediators of observed cell cycle arrest and appear to
act downstream of AMPK activation and cyclin D1 loss. Other
AMPK activators such as AICAR and antimycin A also caused
downregulation of cyclin D1. Downregulation of cyclin D1 may
lead to release of p27 and p21, allowing them to bind to CDK2
and block its activity [30]. Our results also observed the decrease
of cyclinD1, cyclin E and increase of p21, suggesting that activated
AMPK by LETM1 inhibits G1/S cell cycle progression (Fig. 3 and
Fig. 4). Recently, activated AMPK was shown to phosphorylate at
Ser15 of p53, a modification that is known to protect the protein
from degradation and promote cell cycle arrest during DNA
damage [31]. In our study, activated AMPK by LETM1 led to a
significant increase in p53 phosphorylation on Sernine15 resulting
in cell cycle arrest (Fig. 3D and Fig. 4E).
We also found that overexpression of LEMT1 promoted
apoptosis of lung cancer cells. The underlying mechanisms of
these effects can relate to the role of LETM1 in the regulation of
mitochondrial functions. Mitochondria are known to take active
part in the apoptotic process by various mechanisms including
energy metabolism, disruption of electron transport. The mito-
chondria apoptosis pathway is signified by the release of
cytochrome c, a change in the mitochondria morphology and
permeability. Bax interacts with intrinsic mitochondria proteins
such as voltage-dependent anion channel to induce cytochrome c
release from mitochondria [32]. Similarly, our studies found that
overexpression of LETM1 induced Bax as well as cytochrome c
release from mitochondria (Fig. 6). We also detected fragmented
mitochondria and disorganization of mitochondrial cristae in
adenovirus LETM1 infected cells as well as murine lung (Fig. 5),
suggesting that LETM1 may play an important role in
mitochondrial apoptosis.
Taken together these results demonstrated that such activation
of AMPK activity led to cell cycle arrest and induction of apoptosis
closely associated with LETM1 overexpression may play a key role
in suppressing the lung cancer growth and progression (summery
in table1 and Figure S4). In conclusion, our data suggest that
LETM1 suppressed lung tumor growth through activation of
AMPK activity and inhibition of Akt activity. Therefore,
understanding the role of LETM1 may be important in developing
effective therapeutics for lung cancer. Also, our current results in
combination of detailed new information of the mechanism of
AMPK action would provide us a good rationale to take LETM1
as a candidate for cancer therapy.
Materials and Methods
Antibodies and Reagents
Monoclonal antibodies against Akt1 and phospho-Akt at Ser473
were generated via a general method described elsewhere [33].
Anti-LETM1 antibody was purchased from Novus Biological
(Littleton, CO, USA). Anti-COX IV, anti-VDAC, anti-Hsp60,
anti-SDHA, anti-AIF and anti-ND 6 antibodies were purchased
from Abcam (Cambridge, MA, USA). Anti-phospho-Akt at
Thr308, anti-Bax, anti-BclxL, anti-cyclinE, anti-cyclinD1, anti-
cyclinE, anti-p27, anti-p21, anti-CDK4, anti-AMPK, anti-cyto-
chrome c anti-CD31, anti-VEGF, anti-MMP-2, anti-MMP-9 and
anti-Actin antibodies were from Santa Cruz Biotechnology (Santa
Cruz, CA, USA). Anti-cleaved PARP, anti-phospho-p53 at Ser15,
anti-p53, anti-phospho-AMPK at Thr172, anti-mTOR, and anti-
phospho-mTOR at Ser2448 antibodies were obtained from Cell
Signaling (Danvers, MA, USA). HRP conjugated anti-mouse and
anti-rabbit IgG antibodies were from Zymed (San Francisco, CA,
USA).
Cell culture, Adenovirus infection
Human non-small cell lung cancer cell A549 was purchased
from American Tissue Type Culture Collection (ATCC, Mana-
ssas, VA, USA). The cells were maintained in RPMI 1640
(Invitrogen, Carlsbad, CA, USA) with 10% heat-inactivated fetal
calf serum (FCS), 100,000 units/L penicillin, and 100 mg/L
streptomycin (Invitrogen) at 37uCi n5 %C O 2 incubator. Stable
cell lines expressing pDsRed-Mito were isolated after selecting for
3 weeks with G418 (Sigma-Aldrich, St. Louis, MO, USA).
Adenoviral expression vector for wild-type LETM1 (LETM1),
GFP, shRNA LETM1 and MTS-deleted LETM1 were prepared
by using Adenoviral Expression Kit (Invitrogen). A549 cells were
infected with the appropriate adenovirus-LETM1, adenovirus-
GFP, adenovirus-shRNA LETM1 and adenovirus- MTS-deleted
LETM1 (10
4 PFU/ml) for the indicated time when cells reached
80% confluence. The medium was changed 6 h post-infection,
and incubation for 48 h.
Flow cytometrical analysis of cell cycle
Cells were cultured in 6-well plates and infected with
adenovirus-LETM1, adenovirus-GFP for designated time points.
Cell attached to the plate were collected with trypsin, washed, and
resuspended in 100 ml of PBS, and 5 ml of 70% ethanol was added
slowly while continuous vortexing of cells and were fixed
overnight. Next day, cell were spun, washed, and suspended in
400 ml of PBS with addition of 10 mg/L RNase A and 75 mM
Figure 4. LETM1 induced cell cycle arrest at the G1/S phases in vitro. The 9 weeks K-ras
LA1 mice were exposed to aerosols containing
adenovirus-LETM1 twice a week for total 4 weeks. Lung tissue homogenates were subjected to western blot analysis. (A) Expression of p21, cyclinE,
cyclinD1, CDK4, p27, phospho-p53 at Ser15 and p53 proteins. (B) The bands-of-interest were further analyzed by densitometry (n=8). (C)
Immunohistochemistry analysis of phospho-p53 at Ser 15. Dark brown color indicates the expression (Scale bar=20 mm). (D) Comparison of
phospho-p53 at Ser15 labeling index. The phospho-p53 at Ser15 positive staining was determined by counting 10 randomly chosen fields per
section, determining the percentage of DAB positive cell per 100 cells. Each bar represents mean6SE (n=8), *P,0.05 was considered significant and
**P,0.01 highly significant compared with corresponding control values. (E) Reversal of LETM1-mediated events by MTS-deleted LETM1-adenovirus
and shRNA-LETM1. Expression of phospho-Akt1 at Thr308, phospho-Akt1 at Ser473, Akt1, phospho-AMPK at Thr172, AMPK, cyclinD1, phospho-p53 at
Ser15 and p53 proteins.
doi:10.1371/journal.pone.0012535.g004
LETM1 Suppresses Lung Cancer
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San Jose, CA, USA).
Small interference RNA (siRNA) and small hairpin RNA
(shRNA) transfection
To knock down the endogenous LETM1, A549 cells were
transiently transfected with 10 nM of the chemically synthesized
siRNAs/shRNAs targeting AMPK and/or LETM1 or with the
nonsilencing control siRNA/shRNA using Transfection Reagent
according to the manufactor’s recommendations (Santa Cruz
Biotechnology). Whole cell lysates were prepared 48 h after
transfection. siRNA/shRNA sequences used in the present study
are available upon request.
Measurement of mitochondria ATP
Wild-type firefly luciferase from pGL3-base vector was
subcloned into pcDNA3.1-HA vector. For the mitochondrial
luciferase (Luc-m), it was fused downstream of the sequence
encoding the mitochondrial targeting signal (MTS) of subunit 8 of
cytochrome c oxidase. The COX 8 targeting sequence has been
Figure 5. LETM1 induced mitochondrial dysmorphology. (A) A549 cells that stably expressed mitochondrion-targeted Mito-DsRed were
infected with GFP (Ad-GFP), LETM1-adenovirus (Ad-LETM1) or without adenovirus (Control) for 48 h and imaged via confocal microscopy. (B)
Mitochondrial ultrastructure was analyzed by transmission electron microscopy in A549 cells. (C) Mitochondrial ultrastructure was analyzed by
transmission electron microscopy in the lungs of 9 weeks K-ras
LA1 mice. Bottom panels are the magnification of the indicated area (Scale
bar=100 nm).
doi:10.1371/journal.pone.0012535.g005
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PLoS ONE | www.plosone.org 9 September 2010 | Volume 5 | Issue 9 | e12535Figure 6. LETM1 induced apoptosis. A549 cells was infected with GFP (Ad-GFP), LETM1 (Ad-LETM1), or without adenovirus (Control). (A) Western
blot analysis of the release of cytochrome c from mitochondria. (B) The bands-of-interest were further analyzed by densitometry. Each bar represents
mean6SE (n=3), *P,0.05 was considered significant and **P,0.01 highly significant compared with corresponding control values. The 9 weeks K-
ras
LA1 mice were exposed to aerosols containing adenovirus-LETM1 twice a week for total 4 weeks. Lung tissue homogenates were subjected to
Western blot analysis. (C) Expression level of BAX, BclxL, PARP proteins. (D) The bands-of-interest were further analyzed by diameter. (E)
Immunohistochemical analysis of cleaved PARP. Dark brown color indicates the expression (Scale bar=20 mm). (F) Comparison of cleaved PARP
labeling index. Cleaved PARP positive staining was determined by counting 10 randomly chosen fields per section, determining the percentage of
DAB positive cell per 50 cells. Each bar represents mean6SE (n=8), *P,0.05 was considered significant and **P,0.01 highly significant compared
with corresponding control values.
doi:10.1371/journal.pone.0012535.g006
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PLoS ONE | www.plosone.org 10 September 2010 | Volume 5 | Issue 9 | e12535Figure 7. LETM1 suppressed tumor growth. The 9 weeks K-ras
LA1 mice were exposed to aerosols containing adenovirus-LETM1 twice a week for
total 4 weeks. Lung tissue homogenates were subjected to western blot analysis. (A) Expression of LETM1 and PCNA proteins. (B) The bands-of-
interest were further analyzed by densitometry. (C) Immunohistochemistry analysis of LETM1 (upper panel; Scale bar=20 mm) and PCNA (lower
panel; Scale bar=20 mm). Dark brown color indicates the expression. (D) Comparison of LETM1 (left) and PCNA (right) labeling index. LETM1 and
PCNA positive staining was determined by counting 10 randomly chosen fields per section, determining the percentage of DAB positive cell per 100
cells. Each bar represents mean6SE (n=8). *P,0.05 was considered significant and **P,0.01 highly significant compared with corresponding control
values. (E) K-ras
LA1 mice lungs with whitish multiple nodules in the lung (green arrows). (F) Histological examination of K-ras
LA1 mice lungs (Scale
bar =100 mm).
doi:10.1371/journal.pone.0012535.g007
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and a similar COX 8-luciferase construct was shown to be
targeted appropriately to the mitochondrial matrix [34]. Light
emission was measured in a luminometer at 5-S intervals until the
maxium value of luminescence was reached. To normalize for the
variability of luciferase expression in transfected cells, the relative
luminescence values in each cell compartment were expressed as a
ratio to the total potential luminescence measured on equal
aliquots of the same lysed cells with a luciferase assay kit (Promega,
Madison, USA) in the presence of excess ATP.
Transmission electron microscopy (TEM)
A549 cells and lung cancer tissue were fixed with a solution of
2.5% glutaraldehyde with 1% Osimium tetroxide (OsO4) buffer
for 2 h at 4uC and dehydrated with ethanol at 4uC. Then cells and
tissues were infiltrated in a 1:1 mixture of propylene oxide and
Epon and finally embedded in Epon by polymerization at 70uC for
24 h. Ultrathin sections (40–70 nm) were cut and mounted on
pioloform-coated copper grids. Sections were stained with lead
citrate and uranyl acetate and viewed with a JEM 1010
transmission electron microscope (JEOL, Tokyo, Japan).
Confocal imaging analysis and indirect
immnuofluorescence
Mitochondria expression stable cells (pDsRed-Mito) were grown
2-well chamber slides until 50–70% confluent and then infected
with adenovirus-GFP or adenovirus-LETM1 for 6 h. After 48 h,
the cells were fixed with 4% paraformaldehyde at room
temperature for 10 min, mount with Dakocytomation Faramount
Aqueous Mounting solution (Dakocytomation, carpinteria, CA,
USA) and visualized using a Carl Zeiss confocal microscope (Carl
Zeiss MicroImaging, Thronwood, NY, USA). For indirect immu-
nofluorescence, A549 cells were fixed with 4% paraformaldehyde at
room temperature for 10 min and permeabilized with 1% Triton
X-100 at room temperature for 15 min. Then cells were incubated
in blocking buffer containing 3% bovine serum albumin (Sigma) in
16 TBS for 1 h at 37uC. The mouse monoclonal anti-phospho-
AMPK (Thr172) was diluted 200 fold for primary antibody and
incubatedforovernight.Thesecondaryantibody,FITC-conjugated
anti-mouse antibody (BD Biosciences) was used. After appropriate
rinsing, coverslips were mounted in Dakocytomation Faramount
Aqueous Mounting solution on glass slides and analyzed.
Isolation of mitochondria and cytosolic protein
A549 cells were washed with PBS and resuspended in
mitochondrial fraction buffer (20 mM HEPES, pH 8.0, 10 mM
KCl, 1.5 mM MgCl2, 1 mM EDTA, 250 mM sucrose, 1 mM
PMSF, 10 g/ml leupeptin, 10 g/ml aprotinin, and 0.2 mM
sodium orthovanadate) for 30 min on ice, and then homogenized.
Unbroken cells and nuclei were pelleted by centrifugation at
1500 g for 10 min. The supernatant was continuously centrifuged
at 10,000 g for 30 min at 4uC and transferred to a new tube for
the post-mitochondrial fraction. Next, the supernatant was
centrifuged at 100,000 g for 1 h at 4uC, and the supernatant
was used as a cytosolic fraction. The post-mitochondrial fraction
pellet was washed with 500 ml of mitochondrial fraction buffer,
and used for isolation of the mitochondrial fraction. The
supernatant and mitochondrial fractions were collected and
protein concentration was determined by the Bradford assay.
Equivalent amounts of protein were loaded and electrophoresed
on SDS–polyacrylamide gels. The membrane was incubated with
the following primary antibodies: mouse anti-cytochrome c (Santa
Cruz) and rabbit anti-HSP60 (Abcam, Cambridge, MA, USA)
followed by incubation with ahorseradish peroxidase conjugated
secondary antibodies.
In vivo aerosol delivery of adenovirus-LETM1
Experiments were carried out on 9-week-male K-ras
LA1 mice
(8mice/group). The breeding mice were obtained from Human
Cancer Consortium-National Cancer Institute (Frederick, MD,
USA) and kept in the laboratory animal facility with temperature
and relative humidity maintained at 2362uC, with a and 50620%
respectively and were kept on a 12- hour light/dark cycle. All
methods used in this study were approved by the Animal Care and
Use Committee at Seoul National University (SNU-071210-7).
For gene delivery, mice were placed in nose-only exposure
chamber and exposed to the aerosol based on the methods used
previously. Our aerosol gene delivery methods have been
successfully applied in diverse studies [33,35,36,37,38]. For the
effects of LETM1 against lung cancer development, the K-ras
LA1
mice were divided into three groups. Control group was not
treated with anything and other two groups were exposed to
aerosol containing adenovirus-GFP or adenovirus-LETM1 (5610
6
PFU/ml). The K-ras
LA1 mice were exposed to aerosols twice a
week for total 4 weeks. At the end of the study, K-ras
LA1 mice were
sacrificied, and the lungs were collected. During the autopsy
procedure, the neoplastic lesions of lung surfaces were carefully
counted and the lesion diameter was measured with the aid of
digital calipers under microscope as described [39]. Simultaneous-
ly, the lungs were perfused and fixed in 10% neutral-buffered
formalin for histophathological studies.
Histopathological analysis and immunohistochemistry
(IHC)
The lung tissues were fixed in 10% neutral buffered formalin-
fixed, paraffin-embedded tissue section were cut and transferred to
plus slides (Fisher Scientific, Pittsburgh, PA, USA). For histological
analysis, the tissue sections were stained with hematoxylin and
eosin (H&E). For IHC, the tissue section were deparaffinized in
xylene and rehydrated through alcohol gradients, then washed
and incubated in 3% hydrogen peroxide (AppliChem, Boca
Raton, FL, USA) for 30 min to quench endogenous peroxidase
activity. After washing in PBS, the tissue sections were incubated
with 3% BSA in PBS for 1 h at room temperature to block the
unspecific binding sites. Primary antibodies were applied on tissue
section for overnight. The following day, the tissue sections were
washed and incubated with secondary HRP-conjugated antibodies
(1:50; Zymed) for 2 hr at room temperature. After washing, tissue
sections were counterstained with Mayer9s Hematoxylin (DAKO,
Carpinteria, CA, USA) and washed with xylene. Cover slips were
Table 1. Summary of tumor incidence in the lungs of K-ras
LA1
mice.
Group NO Tumor number Adenoma Hyperplasia
CON 8 10.662.26 A(5)
++ B(3)
+++
GFP 8 10.763.27 A(4)
+++ B(4)
+++
LETM1 8 6.3761.99** A(2)
+ B(6)
++
A, alveolar/bronchiolar adenoma; B, alveolar epithelial cell hyperplasia.
No, number of K-ras
LA1 mice per group.
CON, control; GFP, adenovirus-GFP treated group; LETM1, adenovirus-LETM1
treated group.
( ), number of mice.
Grade: +, minimal; ++, mild; +++, severe.
**, denote statistical different (**, p,0.01) compared to control.
doi:10.1371/journal.pone.0012535.t001
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reviewed using alight microscope (Carl Zeiss). Staining intensity of
phospho-p53 at Ser15, LETM1, PCNA, ki-67, BCLxL and
cleaved PARP for quantification of IHC analysis were performed
using In Studio version 3.01 programs (Pixera, San Jose, CA,
USA). Staining intensity was assessed by counting the number of
positive cells in randomly selected fields viewed with appropriate
magnification of objective lens.
Western Blot Analysis
Cells and tissue were placed on ice and extracted with lysis
buffer containing 50 mM Tris-HCl, pH 7.5, 1% v/v Nonidet P-
40, 120 mM NaCl, 25 mM sodium fluoride, 40 mM glycerol
phosphate, 0.1 mM sodium orthovanadate, 1 mM phenylmethyl-
sulfonyl fluoride, 1 mM benzamidine, and 2 mM microcystin-LR.
Lysates were centrifuged for 15 min at 12,000 g. Cell extracts
were resolved by 12% SDS-PAGE and transferred to nitrocellu-
lose membranes (Amersham Pharmacia, Pittsburgh, PA, USA).
The membranes were blocked for 1 hr in TTBS (Tris-buffered
saline+Tween 20) containing 5% skim milk, and immunoblotting
was done by incubating overnight, and then with secondary
antibodies conjugated to horseradish peroxides (HRP) for 3 hours
at room temperature or overnight. After washing, the bands-of-
interests were pictured by luminescent image analyzer LAS-3000
(Fujifilm, Tokyo, Japan), and quantification of Western blot
analysis was done by using multi Gauge version 2.02 program
(Fujifilm).
Mitochondrial membrane potential analysis
To analyze the mitochondria membrane potential, A549 cells
were cultured in 2well-chamber slide and infected with adenovi-
rus-LETM1 (LETM1), adenovirus-GFP (GFP) and for 6 h. After
48 h, cell were incubated 20 min with JC-1 (5,59,69,69-tetrachloro-
1,19,3,39-tetaethylbenzimi-dazolylcarbocyanine iodide, Molecular
Probes) in culture medium. The dye concentrates in mitochondria
maintaining a high membrane potential and forms aggregates
having a red emission spectrum. The monomeric form of JC-1 has
a green emission spectrum. After rinsing the slides, the red and
green emissions of JC-1 were detected with the TRITC and FITC
photomultipliers of the confocal microscope, respectively. Fluo-
rescence images visualized using a Carl Zeiss confocal microscope
(Carl Zeiss MicroImaging).
Flow cytometrical analysis of apoptosis
Cells were cultured in T-75 Flask and infected with adenovirus-
LETM1, adenovirus-GFP for 6 h. After 48 h, cell were collected
with trypsin, washed, and resuspended in 16Binding Buffer at a
concentration of 1610
6/ml and 100 ml of the solution (5610
5
cells) were transferred in a 5 ml FACS tube and combined with
1 ml Annexin V/FITC and 1 ml propidium iodide. After
incubation for 30 min at room temperature in the dark, 300 ml
of 16Binding Buffer were added to each tube. The rate apoptosis
was measured using the Annexin V/FITC apoptosis detection kit
(Abcam) with FACS Calibur (BD Bioscience).
Gelatin zymography assay
The tumor tissues were homogenized and protein was
measured using the Bradford kit (Bio-Rad). Equal amounts of
protein were electrophoresed in 10% SDS-polyacrylamide gel
containing 1% gelatin. The gel was then washed at room
temperature for 2 h with 2.5% Triton X-100 and subsequently
incubated at 37uC in a buffer containing 10mmol/L CaCl2,
150mmol/L NaCl, and 50mmol/L Tris–HCl (pH 7.5) for 48 h.
The gel was then stained with Coomassie blue to visualize
gelatinolytic activity.
Statistical Analysis
Data are expressed as the mean 6 S.E. from at least three
separate experiments performed triplicate. The differences be-
tween groups were analyzed using a Student’s t test (Graphpad
Software, San Diego, CA, USA). p,0.05 (*) was considered
significant, and p,0.01 (**) was highly significant compared with
corresponding control values. Quantification of western blot
analysis was done by using Multi Gauge Version 2.02 program
(Fujifilm).
Supporting Information
Figure S1 LETM1 decreased mitochondrial membrane poten-
tial and induced apoptosis in A549 cells. (A) Confocal pictures of
cells stained with JC-1 dye. The JC-1 red to green ratio was used
to monitor mitochondria membrane potential. The red fluores-
cence of JC-1 monomers indicates high mitochondria membrane
potential while green fluorescence of JC-1 monomers indicates
mitochondria with depolarized membranes. (B) Cell proliferation
assay. (C) Apoptotic cell-death was measured using the Annexin
V/FITC apoptosis detection kit (Abcam) with FACS Calibur (BD
Bioscience). Quatitative measurement of Annexin V/FITC flow
cytometry analyses showing positive apoptotic cells.
Found at: doi:10.1371/journal.pone.0012535.s001 (0.69 MB TIF)
Figure S2 Effect of aerosol-delivered LETM on lung tumor
angiogenesis. (A) Gelatin zymography assay and western blot
analysis for activity of matrix metalloproteinase-2 (MMP-2). (B)
The bands-of-interest were further analyzed by diameter. (C)
Western blot analysis of VEGF, CD31and MMP-9 proteins in the
lungs of K-ras
LA1 mice. (D)The bands-of-interest were further
analyzed by diameter.
Found at: doi:10.1371/journal.pone.0012535.s002 (1.38 MB TIF)
Figure S3 Immunohistochemistry of ki-67 and BCLxL in the
lungs of K-ras
LA1 mice. (A) Immunohistochemistry analysis of ki-
67 in the lung. Dark brown color indicates the Ki-67 expression
(magnification, X 100 and X400). (B) Comparison of ki-67
labeling index. ki-67 positive staining was determined by counting
10 randomly chosen fields per section, determining the percentage
of DAB positive cell per 50 cells. (C) Immunohistochemistry
analysis of BCLxL in the lung. Dark brown color indicates the
BCLxL expression (magnification, X 100 and X400). (D)
Comparison of BCLxL labeling index. BCLxL positive staining
was determined by counting 10 randomly chosen fields per
section, determining the percentage of DAB positive cell per 50
cells. Each bar represents mean6SE (n=8), *P,0.05 was
considered significant and **P,0.01 highly significant compared
with corresponding control values.
Found at: doi:10.1371/journal.pone.0012535.s003 (0.42 MB TIF)
Figure S4 Schematic signal pathway by which LETM1
regulates lung cancer cell growth. LETM1 induced the activation
of AMPK. Such activated AMPK inhibited Akt/mTOR signaling
pathway and cyclinD1 expression level then decreased p53 and
p21 expression level resulting in induction of apoptosis.
Found at: doi:10.1371/journal.pone.0012535.s004 (0.32 MB TIF)
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